Upregulation of Mitochondrial Uncoupling Protein-2 by the AMP-Activated Protein Kinase in Endothelial Cells Attenuates Oxidative Stress in Diabetes
Open Access
- 1 December 2008
- journal article
- retracted article
- Published by American Diabetes Association in Diabetes
- Vol. 57 (12), 3222-3230
- https://doi.org/10.2337/db08-0610
Abstract
OBJECTIVE—Recent evidence suggests that the AMP-activated protein kinase (AMPK) is an important therapeutic target for diabetes. The present study was conducted to determine how AMPK activation suppressed tyrosine nitration of prostacyclin synthase in diabetes. RESEARCH DESIGN AND METHODS—Confluent human umbilical vein endothelial cells (HUVECs) or mice were treated with 5-amino-4-imidazole carboxamide riboside (AICAR) for the detection of AMPK phosphorylation and the expression of mitochondrial uncoupling protein (UCP)-2. RESULTS—Exposure of HUVECs to high glucose (30 mmol/l) increased superoxide anions (O2·−) and prostacyclin synthase nitration. In addition, overexpression of constitutively active AMPK (Ad-CA-AMPK) or the addition of AICAR reduced both O2·− and prostacyclin synthase nitration caused by high glucose, whereas adenoviral overexpression of dominant-negative AMPK mutants (Ad-DN-AMPK) enhanced the latter effects of high glucose. Exposure of HUVECs to either AICAR or metformin caused AMPK-dependent upregulation of both UCP-2 mRNA and UCP-2 protein. Furthermore, overexpression of UCP-2 significantly ablated both O2·− and prostacyclin synthase nitration triggered by high glucose. Furthermore, overexpression of Ad-CA-AMPK increased, whereas overexpression of Ad-DN-AMPK inhibited AICAR-induced phosphorylation of p38 kinase at Thr180/Tyr182. Inhibition of p38 kinase with SB239063, which had no effect on AICAR-induced AMPK-Thr172 phosphorylation, dose dependently suppressed AICAR-induced upregulation of UCP-2, suggesting that AMPK lies upstream of p38 kinase. Finally, AICAR markedly increased UCP-2 expression and reduced both O2·− and prostacyclin synthase nitration in diabetic wild-type mice but not in their AMPKα2-deficient counterparts in vivo. CONCLUSIONS—We conclude that AMPK activation increases UCP-2, resulting in the inhibition of both O2·− and prostacyclin synthase nitration in diabetes.Keywords
This publication has 56 references indexed in Scilit:
- Redox Signaling, Vascular Function, and HypertensionAntioxidants and Redox Signaling, 2008
- Bypassing the glucose/fatty acid cycle: AMP-activated protein kinaseBiochemical Society Transactions, 2003
- The relative order of mKATP channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heartCardiovascular Research, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Superoxide activates mitochondrial uncoupling proteinsNature, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Insulin and Contraction Directly Stimulate UCP2 and UCP3 mRNA Expression in Rat Skeletal Muscle in VitroBiochemical and Biophysical Research Communications, 2001
- AMP-Activated Protein Kinase Is Activated by the Stimulations of Gq-Coupled ReceptorsBiochemical and Biophysical Research Communications, 2000
- AMP‐activated protein kinase phosphorylation of endothelial NO synthaseFEBS Letters, 1999
- The activation of p38 MAPK by the β-adrenergic agonist isoproterenol in rat epididymal fat cellsFEBS Letters, 1998